Is Cisplatin-Induced Cell Death Always Produced by Apoptosis?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Andrews, 1990, Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance., Cancer Cells, 2, 35
Bruhn, 1992, Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin., Proc Natl Acad Sci USA, 86, 8328
Coleman, 2000, Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin., Mol Pharmacol, 57, 324
Dive C Wyllie AH (1993) Apoptosis and cancer chemotherapy. in Frontiers in Pharmacology, eds Hickman JA Tritton TR (Blackwell Scientific Press, Oxford, United Kingdom), pp 21–56.
Eastman A (1999) The mechanism of action of cisplatin: From adducts to apoptosis. in Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, ed Bernhard Lippert (Wiley-VCH, Basel, Switzerland), pp 111–134.
Eguchi, 1997, Intracellular ATP levels determine cell death fate by apoptosis or necrosis., Cancer Res, 57, 835
Eliopoulos, 1995, The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2., Oncogene, 11, 1217
Evans, 1994, Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocites is dependent of the levels of drug accumulation and DNA adduct formation., Cancer Res, 54, 1596
Gately, 1993, Cellular accumulation of the anticancer agent cisplatin: A review., Br J Cancer, 67, 1171, 10.1038/bjc.1993.221
Henkels, 1997, Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines., Cancer Res, 57, 4488
Henkels, 1999, Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines., Cancer Res, 59, 3077
Hughes, 1992, Purification of nuclear proteins that bind to cisplatin-damage DNA: Identity with high mobility group proteins 1 and 2., J Biol Chem, 267, 13520, 10.1016/S0021-9258(18)42242-9
Jones, 1998, Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between Bax and Bak up-regulation and the functional status of p53., Mol Pharmacol, 53, 819
Peitsch, 1993, Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis., EMBO J, 12, 371, 10.1002/j.1460-2075.1993.tb05666.x
Pérez, 2000, Current status of the development of trans-platinum antitumor drugs., Crit Rev Oncol/Hematol, 35, 109, 10.1016/S1040-8428(00)00053-6
Reed E (1999) Cisplatin. in Cancer Chemotherapy and Biological Response Modifiers, eds Pinedo HM Longo DL Chabner BA (Elsevier Science BV, Amsterdam), pp 144–151.
Reed JC (1997) Bcl-2 family proteins: Role in dysregulation of apoptosis and chemoresistance in cancer. in Apoptosis and Cancer, ed Martin SJ (Karger-Landes Systems, Basel, Switzerland), pp 64–97.
Rosenberg B (1999) Platinum complexes for the treatment of cancer: Why the search goes on. in Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, ed Bernhard Lippert (Wiley-VCH, Basel, Switzerland), pp 3–27.
Sánchez-Prieto, 2000, A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents., Cancer Res, 60, 2464
Sklar, 1991, Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc., Cancer Res, 51, 2118
Sorenson, 1988, Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient chinese hamster ovary cells., Cancer Res, 48, 6703
Zamble DB Lippard SJ (1999) The response of cellular proteins to cisplatin-damage DNA. in Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, ed Bernhard Lippert (Wiley-VCH, Basel, Switzerland), pp 74–110.
Zhan, 1997, A role for c-myc in chemically induced renal-cell death., Mol Cell Biol, 17, 6755, 10.1128/MCB.17.11.6755